Effects of bisphosphonates on osteoclastogenesis in RAW264.7 cells

International Journal of Molecular Medicine

Volumn 29, Issue 6, 2012, Pages 1007-1015

  Abe, Keigo ^a   Yoshimura, Yoshitaka ^a   Deyama, Yoshiaki ^a   Kikuiri, Takashi ^a   Hasegawa, Tomokazu ^b   Tei, Kanchu ^a   Shinoda, Hisashi ^c   Suzuki, Kuniaki ^a   Kitagawa, Yoshimasa ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c TOHOKU UNIVERSITY   (Japan)

Author keywords

Nitrogen containing bisphosphonates; Non nitrogen containing bisphosphonates; Osteoclast

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CASPASE 3; CASPASE 7; DNA FRAGMENT; ETIDRONIC ACID; MESSENGER RNA; NITROGEN DERIVATIVE; OSTEOCLAST DIFFERENTIATION FACTOR; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; RISEDRONIC ACID; TRK 530; UNCLASSIFIED DRUG; ZOLEDRONIC ACID;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL COUNT; CELL DIFFERENTIATION; CELL NUCLEUS; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME ASSAY; GENE EXPRESSION; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION;

ACID PHOSPHATASE; ANIMALS; APOPTOSIS; BIOLOGICAL ASSAY; BIOLOGICAL MARKERS; CASPASE 3; CASPASE 7; CELL COUNT; CELL DIFFERENTIATION; CELL LINE; DIPHOSPHONATES; DNA FRAGMENTATION; ELECTROPHORESIS, AGAR GEL; GENE EXPRESSION REGULATION; GIANT CELLS; ISOENZYMES; MICE; OSTEOCLASTS; OSTEOGENESIS; RNA, MESSENGER; TIME FACTORS;

EID: 84860502861     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2012.952     Document Type: Article

References (26)

1. Väänänen HK and Laitala-Leinonen T: Osteoclast lineage and function. Arch Biochem Biophys 473: 132-138, 2008.
2. Boyle WJ, Simonet WS and Lacey DL: Osteoclast differentiation and activation. Nature 423: 337-342, 2003. (Pubitemid 40852708)
3. Yoshida H, Hayashi S, Kunisada T, et al: The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345: 442-444, 1990. (Pubitemid 120014957)
4. Lolli ML, Rolando B, Tosco P, et al: Synthesis and preliminary pharmacological characterisation of a new class of nitrogen-containing bisphosphonates (N-BPs). Bioorg Med Chem 18: 2428-2438, 2010.
5. Shinoda H, Takeyama S, Suzuki K, Murakami S and Yamada S: Pharmacological topics of bone metabolism: a novel bisphosphonate for the treatment of periodontitis. J Pharmacol Sci 106: 555-558, 2008. (Pubitemid 351556232)
6. Kimachi K, Kajiya H, Nakayama S, Ikebe T and Okabe K: Zoledronic acid inhibits RANK expression and migration of osteoclast precursors during osteoclastogenesis. Naunyn Schmiedebergs Arch Pharmacol 383: 297-308, 2011.
7. Kwak HB, Kim JY, Kim KJ, et al: Risedronate directly inhibits osteoclast differentiation and inflammatory bone loss. Biol Pharm Bull 32: 1193-1198, 2009.
8. Weinstein RS, Roberson PK and Manolagas SC: Giant osteoclast formation and long-term oral bisphosphonate therapy. N Engl J Med 360: 53-62, 2009.
9. Seo SW, Cho SK, Storer SK and Lee FY: Zoledronate reduces unwanted bone resorption in intercalary bone allografts. Int Orthop 34: 599-603, 2010.
10. Suzuki N, Yoshimura Y, Deyama Y, Suzuki K and Kitagawa Y: Mechanical stress directly suppresses osteoclast differentiation in RAW264.7 cells. Int J Mol Med 21: 291-296, 2008. (Pubitemid 351330479)
11. Ishida Y, Agata Y, Shibahara K and Honjo T: Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J 11: 3887-3895, 1992.
12. Reginster JY, Malaise O, Neuprez A, Jouret VE and Close P: Intermittent bisphosphonate therapy in postmenopausal osteoporosis: progress to date. Drugs Aging 24: 351-359, 2007. (Pubitemid 46790260)
13. Clarke NW: Skeletal preservation in prostate cancer: the changing role of the urologist. Eur Urol Suppl 5: 871-872, 2006.
14. Santini D, Vespasiani Gentilucci U, Vincenzi B, et al: The antineoplastic role of bisphosphonates: from basic research to clinical evidence. Ann Oncol 14: 1468-1476, 2003. (Pubitemid 37304600)
15. Ruggiero SL, Mehrotra B, Rosenberg TJ and Engroff SL: Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 62: 527-534, 2004. (Pubitemid 38542516)
16. Marx RE, Sawatari Y, Fortin M and Broumand V: Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 63: 1567-1575, 2005. (Pubitemid 41525412)
17. Dannemann C, Gratz KW, Riener MO and Zwahlen RA: Jaw osteonecrosis related to bisphosphonate therapy: a severe secondary disorder. Bone 40: 828-834, 2007. (Pubitemid 46386541)
18. Urade M, Tanaka N, Furusawa K, et al: Nationwide survey for bisphosphonate-related osteonecrosis of the jaws in Japan. J Oral Maxillofac Surg 69: 364-371, 2011.
19. Ferrara S and Califano L: Current perspectives in the management of patients with drug-induced osteonecrosis of the maxilla: experience of the school of Naples Federico II. Age and Health Forum Catanzaro, Naples, pp5-7, 2009.
20. Takayanagi H: The role of NFAT in osteoclast formation (Review). NY Acad Sci 1116: 227-237, 2007.
21. Zhao Q, Wang X, Liu Y, He A and Jia R: NFATc1: functions in osteoclasts. Int J Biochem Cell Biol 42: 576-579, 2010.
22. Kim K, Lee SH, Kim JH, Choi Y and Kim N: NFATc1 induces osteoclast fusion via upregulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP). Mol Endocrinol 22: 176-185, 2008.
23. Yagi M, Miyamoto T, Sawatani Y, et al: DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells. J Exp Med 202: 345-351, 2005. (Pubitemid 41126951)
24. Kitami S, Tanaka H, Kawato T, et al: IL-17A suppresses the expression of bone resorption-related proteinases and osteoclast differentiation via IL-17RA or IL-17RC receptors in RAW264.7 cells. Biochimie 92: 398-404, 2010.
25. Shibata K, Yoshimura Y, Kikuiri T, et al: Effect of the release from mechanical stress on osteoclastogenesis in RAW264.7 cells. Int J Mol Med 28: 73-79, 2011.
26. Hughes DE, Wright KR, Uy HL, et al: Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. J Bone Miner Res 10: 1478-1487, 1995.